Page last updated: 2024-10-21

phenytoin and Cardiotoxicity

phenytoin has been researched along with Cardiotoxicity in 1 studies

Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research Excerpts

ExcerptRelevanceReference
"Doxorubicin (DOX) is an effective anticancer agent, but adverse cardiotoxic effects limit its use."5.43Cardioprotective Effect of Phenytoin on Doxorubicin-induced Cardiac Toxicity in a Rat Model. ( Asadnasab, G; Ashrafi Helan, J; Azarmi, Y; Babaei, H; Mohajjel Nayebi, A; Razmaraii, N, 2016)
"Doxorubicin (DOX) is an effective anticancer agent, but adverse cardiotoxic effects limit its use."1.43Cardioprotective Effect of Phenytoin on Doxorubicin-induced Cardiac Toxicity in a Rat Model. ( Asadnasab, G; Ashrafi Helan, J; Azarmi, Y; Babaei, H; Mohajjel Nayebi, A; Razmaraii, N, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Razmaraii, N1
Babaei, H1
Mohajjel Nayebi, A1
Asadnasab, G1
Ashrafi Helan, J1
Azarmi, Y1

Other Studies

1 other study available for phenytoin and Cardiotoxicity

ArticleYear
Cardioprotective Effect of Phenytoin on Doxorubicin-induced Cardiac Toxicity in a Rat Model.
    Journal of cardiovascular pharmacology, 2016, Volume: 67, Issue:3

    Topics: Animals; Breast Neoplasms; Cardiomyopathies; Cardiotoxicity; Cytoprotection; Disease Models, Animal;

2016